Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v4-FR
Language French French
Date Updated 2018-07-26 2017-07-19
Drug Identification Number 02382377 02382377
Brand name MIDAZOLAM INJECTION USP MIDAZOLAM INJECTION USP
Common or Proper name MIDAZOLAM MIDAZOLAM
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients MIDAZOLAM MIDAZOLAM
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size VIAL/AMPOULE VIAL/AMPOULE
ATC code N05CD N05CD
ATC description HYPNOTICS AND SEDATIVES HYPNOTICS AND SEDATIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-07-20
Actual start date 2017-07-07
Estimated end date 2017-11-30
Actual end date 2018-05-24
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Please note that the following formats are currently available: - MIDAZOLAM 5mg/mL 10x1mL GVL - MIDAZOLAM 5mg/mL 10x2mL GVL Please note that the following formats are currently available: - MIDAZOLAM 5mg/mL 10x1mL GVL - MIDAZOLAM 1mg/mL 10x2mL GVL - MIDAZOLAM 1mg/mL 10x5mL GVL
Health Canada comments